Nontuberculous Mycobacterial Infections
📧 Sign up to get email alerts when something new happens for Nontuberculous Mycobacterial Infections.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-11-12Clinical Trial Update: ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation Suspension [Phase 3]
Phase 3 trial MNKD-101 (Clofazimine inhalation suspension) for MAC lung disease was terminated.
-
CLINICAL_TRIALS trial_result · 2019-08-21Clinical Trial Update: Liposomal Amikacin for Inhalation (LAI) for Nontuberculous Mycobacteria [Phase 2]
Phase 2 trial update on liposomal amikacin for inhalation (LAI) for nontuberculous mycobacterial infections; study completed with results po…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Interleukin-12 in the Treatment of Severe Nontuberculous Mycobacterial Infections [Phase 1]
A Phase 1 trial evaluating interleukin-12 for treatment of severe nontuberculous mycobacterial infections has completed.